News & Updates

Show Multimedia Only

Mental disorders carry increased long-term mortality risk for patients with permanent pacemakers

20 Aug 2026

For patients with permanent pacemakers, newly diagnosed mental disorders are associated with elevated risk of long-term mortality, according to a study. The association is especially pronounced among younger men and those with early-onset mental disorders.

Mental disorders carry increased long-term mortality risk for patients with permanent pacemakers

20 Aug 2026

Dementia in a spouse may serve as clinical marker of partner's risk

20 Aug 2026 by

Spouses of individuals with dementia appear to have an increased likelihood of developing the condition themselves, according to a study from Taiwan.

Dementia in a spouse may serve as clinical marker of partner's risk

20 Aug 2026

5-unit IV insulin prevents hypoglycaemia, reduces potassium in adults with hyperkalaemia

20 Aug 2026

Five-unit dosing of intravenous (IV) regular insulin results in lower hypoglycaemia incidence and comparable serum potassium decrease when compared with doses >5 units, according to a study.

5-unit IV insulin prevents hypoglycaemia, reduces potassium in adults with hyperkalaemia

20 Aug 2026

Novel implantable device delivers durable efficacy, high patient satisfaction in women with UUI

20 Aug 2026 by

Revi, an implantable tibial neuromodulation system powered by a patient-controlled, external wearable ankle device, demonstrates durable efficacy, excellent safety profile, and high patient satisfaction in women with urgency urinary incontinence (UUI), a study has shown.

Novel implantable device delivers durable efficacy, high patient satisfaction in women with UUI

20 Aug 2026

Ibuprofen on par with ketorolac for acute musculoskeletal back pain

20 Aug 2026

Both oral ibuprofen 400 mg and intramuscular (IM) ketorolac 10 mg deliver pain relief to individuals with acute, atraumatic, musculoskeletal back pain presenting to the emergency department (ED), according to a study.

Ibuprofen on par with ketorolac for acute musculoskeletal back pain

20 Aug 2026

Biologic-exposed UC patients fare better with upadacitinib vs tofacitinib, ustekinumab

20 Aug 2026

In the treatment of ulcerative colitis (UC) patients with prior advanced therapy failure, subsequent treatment with upadacitinib is associated with higher remission rates compared with tofacitinib and ustekinumab, according to the retrospective TRIDENT-UC study.

Biologic-exposed UC patients fare better with upadacitinib vs tofacitinib, ustekinumab

20 Aug 2026

Fracture risks differ for general & central adiposity in Chinese T2D patients

20 Aug 2026 by

In Chinese patients with type 2 diabetes (T2D), abdominal adiposity and its increases over time are independently associated with higher fracture risk. For general adiposity, the associations are fracture site–specific, with increased risks observed for both weight loss and weight gain.

Fracture risks differ for general & central adiposity in Chinese T2D patients

20 Aug 2026

Optimizing management of multidrug-resistant MBL-producing GN infections

20 Aug 2026 by

Antimicrobial resistance among Gram-negative (GN) bacteria is an urgent global challenge. Infections caused by metallo-β-lactamase (MBL)–producing Enterobacterales and Stenotrophomonas maltophilia are of particular concern due to limited treatment options and high mortality. At an industry-sponsored symposium at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2026, infectious disease experts discussed emerging treatment strategies to improve outcomes, with a focus on the β-lactam/β-lactamase inhibitor combination, aztreonam-avibactam (ATM/AVI).

Optimizing management of multidrug-resistant MBL-producing GN infections

20 Aug 2026

Quizartinib improves survival across FLT3-ITD AML treatment phases and beyond

20 Aug 2026 by

The emergence of FLT3 inhibitors has reshaped the management of patients with acute myeloid leukaemia (AML) with FLT3-internal tandem duplication (ITD) mutations. At an industry-sponsored symposium during The Second Asia Pacific Myeloid Forum (APMF 2026), Professor Adriano Venditti of the University of Rome Tor Vergata in Rome, Italy, discussed the evolving treatment landscape for AML, detailing pivotal results of the QuANTUM-First trial and the potential of the oral, second-generation, type 2 FLT3 inhibitor, quizartinib, to extend survival benefits across all phases of AML therapy and beyond the FLT3-ITD mutation into the wild-type (WT) setting.

Quizartinib improves survival across FLT3-ITD AML treatment phases and beyond

20 Aug 2026

T2D linked to higher number, severity of menopausal symptoms

19 Aug 2026

Midlife women with type 2 diabetes (T2D) appear to experience a greater menopausal symptom burden, both in terms of number and severity, according to an observational study from South Korea.

T2D linked to higher number, severity of menopausal symptoms

19 Aug 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Mental disorders carry increased long-term mortality risk for patients with permanent pacemakers

Mental disorders carry increased long-term mortality risk for patients with permanent pacemakers

Dementia in a spouse may serve as clinical marker of partner's risk

Dementia in a spouse may serve as clinical marker of partner's risk

5-unit IV insulin prevents hypoglycaemia, reduces potassium in adults with hyperkalaemia

5-unit IV insulin prevents hypoglycaemia, reduces potassium in adults with hyperkalaemia

Novel implantable device delivers durable efficacy, high patient satisfaction in women with UUI

Novel implantable device delivers durable efficacy, high patient satisfaction in women with UUI

Ibuprofen on par with ketorolac for acute musculoskeletal back pain

Ibuprofen on par with ketorolac for acute musculoskeletal back pain

Biologic-exposed UC patients fare better with upadacitinib vs tofacitinib, ustekinumab

Biologic-exposed UC patients fare better with upadacitinib vs tofacitinib, ustekinumab

Fracture risks differ for general & central adiposity in Chinese T2D patients

Fracture risks differ for general & central adiposity in Chinese T2D patients

Optimizing management of multidrug-resistant MBL-producing GN infections

Optimizing management of multidrug-resistant MBL-producing GN infections

Quizartinib improves survival across FLT3-ITD AML treatment phases and beyond

Quizartinib improves survival across FLT3-ITD AML treatment phases and beyond

T2D linked to higher number, severity of menopausal symptoms

T2D linked to higher number, severity of menopausal symptoms